RIVERHEAD CAPITAL MANAGEMENT LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,145 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
RIVERHEAD CAPITAL MANAGEMENT LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2019$1,970,000
-31.5%
22,521
-35.9%
0.07%
-31.1%
Q2 2019$2,877,000
+25.9%
35,121
+24.9%
0.11%
+14.0%
Q1 2019$2,286,000
+217.9%
28,121
+157.5%
0.09%
+190.6%
Q4 2018$719,000
-26.6%
10,921
-14.1%
0.03%
-11.1%
Q3 2018$980,000
+0.2%
12,712
-4.0%
0.04%
-7.7%
Q2 2018$978,000
-35.3%
13,242
-43.0%
0.04%
-39.1%
Q1 2018$1,511,000
-28.9%
23,237
-29.3%
0.06%
-28.9%
Q4 2017$2,125,000
-57.5%
32,881
-58.7%
0.09%
-61.5%
Q3 2017$5,000,000
-17.8%
79,675
-20.7%
0.23%
-22.5%
Q2 2017$6,080,000
+62.2%
100,421
+39.0%
0.30%
+46.6%
Q1 2017$3,748,000
+19.9%
72,261
+2.5%
0.21%
+6.7%
Q4 2016$3,127,000
+131.1%
70,521
+148.1%
0.19%
+121.8%
Q3 2016$1,353,000
-42.7%
28,421
-45.5%
0.09%
+135.1%
Q2 2016$2,360,000
-75.6%
52,194
-77.8%
0.04%
-73.0%
Q1 2016$9,681,000
+10.0%
235,633
+2.1%
0.14%
+7.0%
Q4 2015$8,803,000
+11.8%
230,777
-3.7%
0.13%
+3.2%
Q3 2015$7,873,000
-44.1%
239,674
+19.0%
0.12%
-41.8%
Q2 2015$14,087,000
+6.2%
201,450
+4.1%
0.21%
+6.5%
Q1 2015$13,260,000
-4.0%
193,571
+2.7%
0.20%
-4.8%
Q4 2014$13,813,000
+25.4%
188,470
+22.8%
0.21%
+11.1%
Q3 2014$11,016,000
+15.2%
153,500
+16.1%
0.19%
+5.6%
Q2 2014$9,559,000
+13.6%
132,255
+15.7%
0.18%
-2.7%
Q1 2014$8,411,000
-34.6%
114,309
-38.1%
0.18%
+2.2%
Q4 2013$12,853,000
+146.4%
184,802
+132.7%
0.18%
+6.5%
Q3 2013$5,216,000
-31.0%
79,400
-27.2%
0.17%
-32.4%
Q2 2013$7,556,000109,0670.25%
Other shareholders
BAXTER INTL INC shareholders Q4 2019
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders